BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11073271)

  • 1. Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():25-9. PubMed ID: 11073271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical impact of hypercalcemia after kidney transplant].
    Messa P; Cafforio C; Alfieri C
    G Ital Nefrol; 2010; 27(1):47-55. PubMed ID: 20191460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of disturbed calcium metabolism in uraemic patients: 3. Potential perspectives--calcimimetics.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():30-1. PubMed ID: 11073272
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary hyperparathyroidism in chronic renal failure. Role of subtotal parathyroidectomy].
    Tarquini A; Nicolosi A; Massidda B; Bolasco P; Altieri P; Massidda C
    Minerva Chir; 1991 May; 46(10):501-6. PubMed ID: 1922866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia and hyperparathyroidism after renal transplantation.
    Apaydin S; Sariyar M; Erek E; Ataman R; Yiğitbaş R; Hamzaoğlu I; Serdengeçti K; Ulkü U
    Nephron; 1999; 81(3):364-5. PubMed ID: 10050101
    [No Abstract]   [Full Text] [Related]  

  • 7. Involution of the parathyroid glands after renal transplantation.
    Lewin E
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):363-71. PubMed ID: 12815332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum ionized calcium does not suppress parathyroid hormone secretion in a kidney transplanted patient with secondary hyperparathyroidism after total parathyroidectomy and parathyroid transplantation.
    Halabe A
    Nephron; 2001 Jan; 87(1):96. PubMed ID: 11174036
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of hypercalcemia in relation to hyperparathyroidism.
    Pellitteri PK
    Otolaryngol Clin North Am; 2010 Apr; 43(2):389-97, x. PubMed ID: 20510722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment of hyperparathyroidism in renal transplant patients].
    Bellamy J; Benoit G; Hiesse C; Charpentier B
    Prog Urol; 1994; 4(4):509-15. PubMed ID: 7920727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies.
    Muirhead N; Catto GR; Edward N; Adami S; Manning RM; O'Riordan JL
    Br Med J (Clin Res Ed); 1984 Jan; 288(6412):177-9. PubMed ID: 6419845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function.
    Jäger MD; Kaaden S; Emmanouilidis N; Lück R; Beckmann JH; Güner Z; Kespohl H; Glockzin K; Aselmann H; Kaudel CP; Schwarz A; Zapf A; Klempnauer J; Scheumann GF
    Arch Surg; 2011 Jun; 146(6):704-10. PubMed ID: 21690447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical practice guidelines for severe renal hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2004 May; 14(5):786-91. PubMed ID: 15577043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of parathyroid hormone after parathyroidectomy in chronic hemodialysis patients.
    Skalli Z; Elouazzani H; Alhamany Z; Mattous M; Benamar L; Bayahia R; Belkouchi M; El Malki H; Ouzeddoun N
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1199-204. PubMed ID: 26586059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
    Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and quality of control of calcium and phosphorus metabolism disorders among Lithuanian hemodialysis patients in 2004 and 2005].
    Petrauskiene V; Ziginskiene E; Kuzminskis V; Burciuviene A; Grazulis S; Sileikiene E; Masalskiene J; Juodeikiene L; Tamosaitis D; Alisauskiene V
    Medicina (Kaunas); 2007; 43 Suppl 1():58-64. PubMed ID: 17551278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D; Galmozzi C; Pizzocaro G
    Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the different surgical parathyroidectomies on secondary hyperparathyroidism in uremia patients.
    Zhu L; Xiong F; Cui T
    Minerva Endocrinol; 2018 Sep; 43(3):391-393. PubMed ID: 29205012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autologous epithelial body transplantation in the surgical treatment of secondary azotemic hyperparathyroidism].
    Frei U; Klempa I; Fassbinder W; Koch KM
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1315-9. PubMed ID: 611843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.